BWX Technologies Reports Third Quarter 2021 Results, Narrows 2021 Guidance and Strategically Deploys Capital to Repurchase Shares
Lynchburg, VA – November 1, 2021 – BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported third quarter 2021 revenue of $499 million, down 4% compared with $520 million in the third quarter 2020. GAAP net income for the third quarter 2021 was $59.9 million, or $0.63 per diluted share, compared with GAAP […]
BWXT to Restart Existing TRISO Nuclear Fuel Production Line and Expand Capacity
Company to hireup to 60 new workers to attain increased production targets (LYNCHBURG, Va. – Oct. 2, 2019) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it is in the process of restarting its existing TRISO nuclear fuel production line and is planning to expand its existing capacity within approximately 12 months. The expansion […]
BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies […]
BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power
(CAMBRIDGE, ON – August 19, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers. The contract, which will be executed by subsidiary BWXT Canada Ltd. at its Cambridge, Ontario facility, involves engineering and fabrication of these specialized components. Moderator […]
BWX Technologies Reports First Quarter 2021 Results and Commences New Multi-Year Guidance Framework
Highlights: BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported first quarter 2021 revenue of $528 million, a 2.6% decrease compared with $542 million in the first quarter 2020. Net income for the first quarter 2021 was $69.7 million, or $0.73 per diluted share, compared with GAAP net income of $75.5 million, […]
BWXT Announces $2.2 Billion in Contracts for Naval Nuclear Reactor Components and Fuel
(LYNCHBURG, Va. – April 20, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today the award of U.S. Naval Nuclear Propulsion Program contracts totaling approximately $2.2 billion, including future-year options, for the manufacture of naval nuclear reactor components and fuel. “Today’s announcement marks a continuation of a more-than 65-year-old trusted relationship with the U.S. government […]
BWXT Renames Laker Energy Products to BWXT Precision Manufacturing
(OAKVILLE, ON – March 16, 2021) – BWXT Canada Ltd. announced today that it has renamed its subsidiary Laker Energy Products Ltd. to BWXT Precision Manufacturing Inc. BWXT Canada Ltd. acquired Laker Energy Products Ltd. in January of 2020. The Canadian company, founded in 1995, is a leading supplier of nuclear-grade materials and precisely machined […]
BWXT Subsidiary Awarded $57.5 Million Contract to Prepare for Uranium Conversion and Purification Services
(LYNCHBURG, Va. – March 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its Nuclear Fuel Services, Inc. (NFS) subsidiary has received a $57.5 million contract from the National Nuclear Security Administration (NNSA) to prepare for future highly enriched uranium (HEU) conversion and purification services. Under this contract, NFS will provide a final […]
BWX Technologies Reports Solid Fourth Quarter 2020 Results, Marking New Annual Records for Revenue and Earnings and Achieves Long-Term Guidance
View the full report here.
BWXT Names Nuclear Medicine Business as BWXT Medical
(LYNCHBURG, Va. – Feb. 1, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT ITG Canada, Inc., a nuclear medicine company, has been renamed BWXT Medical Ltd. (BWXT Medical), in order to better align with the company’s products, customer base and strategy. BWXT’s entry into the nuclear medicine industry began with […]
